Insight Molecular Diagnostics

(NASDAQ) IMDX

Current Price$6.20

Market Cap$200.52M

Since IPO (2015)-95%

5 Year-93%

1 Year+90%

1 Month+62%

Insight Molecular Diagnostics Financials at a Glance

Market Cap

$200.52M

Revenue (TTM)

$1.95M

Net Income (TTM)

-$47.84M

EPS (TTM)

-$1.48

P/E Ratio

-4.19

Dividend

$0.00

Beta (Volatility)

1.02 (Average)

Dividend

$0.00

Beta (Volatility)

1.02 (Average)

Price

$6.20

Volume

16,465

Open

$6.30

Price

$6.20

Volume

16,465

Open

$6.30

Previous Close

$6.20

Daily Range

$6.07 - $6.49

52-Week Range

$2.33 - $8.51

Dividend

$0.00

Beta (Volatility)

1.02 (Average)

Price

$6.20

Volume

16,465

Open

$6.30

Previous Close

$6.20

Daily Range

$6.07 - $6.49

52-Week Range

$2.33 - $8.51

IMDX News

Why Oncocyte Shot 13% Higher Today

Eric VolkmanFeb 5, 2021

Here's Why OncoCyte Is Giving Back Some Gains Today

Cory RenauerJan 30, 2019

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Insight Molecular Diagnostics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Joshua Riggs

Website

www.oncocyte.com

Headquarters

Nashville, TN 92618, US

IMDX Financials

Key Financial Metrics (TTM)

Gross Margin

19%

Operating Margin

-21%

Net Income Margin

-25%

Return on Equity

-23603%

Return on Capital

-1%

Return on Assets

-1%

Earnings Yield

-23.87%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$200.52M

Shares Outstanding

32.29M

Volume

16.46K

Avg. Volume

348.02K

Financials (TTM)

Gross Profit

$190.00K

Operating Income

-$30.58M

EBITDA

-$28.38M

Operating Cash Flow

-$22.18M

Capital Expenditure

-$3.19M

Free Cash Flow

-$25.37M

Cash & ST Invst.

$11.58M

Total Debt

$3.50M

Insight Molecular Diagnostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$32.00K

-98.5%

Gross Profit

-$605.50K

-145.7%

Gross Margin

-18.92%

N/A

Market Cap

$200.52M

N/A

Market Cap/Employee

$4.36M

N/A

Employees

N/A

Net Income

-$4.29M

+35.7%

EBITDA

-$9.70M

-57.7%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$25.13M

-8.8%

Accounts Receivable

$157.00K

-95.6%

Inventory

$382.00K

-16.8%

Long Term Debt

$1.31M

-37.0%

Short Term Debt

$1.76M

+25.5%

Return on Assets

-1.18%

N/A

Return on Invested Capital

-1.45%

N/A

Free Cash Flow

-$8.25M

-33.9%

Operating Cash Flow

-$7.64M

-30.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PRLDPrelude Therapeutics Incorporated

PRLDPrelude Therapeutics Incorporated$3.92-0.25%

IVVDInvivyd, Inc.

IVVDInvivyd, Inc.$1.14+0.88%

CDXSCodexis, Inc.

CDXSCodexis, Inc.$2.77+0.73%

MISTMilestone Pharmaceuticals Inc.

MISTMilestone Pharmaceuticals Inc.$1.42-1.39%

PEPGPepGen Inc.

PEPGPepGen Inc.$1.50+0.00%

SGMOSangamo Therapeutics, Inc.

SGMOSangamo Therapeutics, Inc.$0.22+4.76%

OABIOmniAb, Inc.

OABIOmniAb, Inc.$2.70-0.74%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCEVirgin Galactic

SPCEVirgin Galactic$6.18+0.36%

FFord Motor Company

FFord Motor Company$17.44+0.05%

SOFISoFi Technologies

SOFISoFi Technologies$18.22+0.07%

ONDSOndas

ONDSOndas$13.22-0.00%

NOKNokia

NOKNokia$14.84-0.03%

SMCISuper Micro Computer

SMCISuper Micro Computer$46.09+0.12%

TAT&T

TAT&T$24.80-0.00%

Questions About IMDX

What is the current price of Insight Molecular Diagnostics?

Insight Molecular Diagnostics is trading at $6.20 per share.

What is the 52-week range for Insight Molecular Diagnostics?

Over the past 52 weeks, Insight Molecular Diagnostics has traded between $2.33 and $8.51.

How much debt does Insight Molecular Diagnostics have?

As of the most recent reporting period, Insight Molecular Diagnostics reported total debt of $3.07M.

How much cash does Insight Molecular Diagnostics have on hand?

Insight Molecular Diagnostics reported $28.93M in cash and cash equivalents in its most recent financial results.

What is Insight Molecular Diagnostics’s dividend yield?

Insight Molecular Diagnostics does not currently have a dividend yield.

Insight Molecular Diagnostics

Insight Molecular Diagnostics Financials at a Glance

IMDX News

Why Oncocyte Shot 13% Higher Today

Here's Why OncoCyte Is Giving Back Some Gains Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Insight Molecular Diagnostics

IMDX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Insight Molecular Diagnostics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IMDX

What is the current price of Insight Molecular Diagnostics?

What is the 52-week range for Insight Molecular Diagnostics?

How much debt does Insight Molecular Diagnostics have?

How much cash does Insight Molecular Diagnostics have on hand?

What is Insight Molecular Diagnostics’s dividend yield?

Premium Investing Services